Magnetic Resonance-Guided Focused Ultrasound for Psychiatric Disorders
Magnetic Resonance-Guided Focused Ultrasound for Psychiatric Disorders
复制标题
DOI:
10.1002/cpt.1467
复制
发表时间:
2019-10-01
影响因子:
6.7
通讯作者:
Lipsman, Nir
中科院分区:
文献类型:
--
作者:
Davidson, Benjamin;Meng, Ying;Lipsman, Nir
Magnetic resonance imaging-guided focused ultrasound (MRgFUS) is an emerging technology that can be used to create precise stereotactic lesions within the brain without an open surgery. MRgFUS is an emerging treatment modality quickly being adopted worldwide in the clinical neurosciences.[4] During the procedure, patients have a stereotactic frame applied under local anesthetic, which is then connected to a helmet lined with 1,024 small ultrasound transducers (B Figure b). MRgFUS thalamotomy has recently become an established treatment for essential tremor, gaining the US Food and Drug Administration and Health Canada approval in 2016 after a successful randomized placebo-controlled trial treating patients with refractory moderate-to-severe essential tremor.[4] As a result, MRgFUS ablative procedures are currently being investigated in other conditions, including treatment-resistant psychiatric conditions, where generating a lesion may be beneficial.[[2],[5]].[Extracted from the article]Copyright of Clinical Pharmacology & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.